Yagin

N/A

Report date: 2022/08/23 20:00:44

Base Information

Drug NameYagin
Drug Alias NameN/A
ClassificationOther
Mechanisms of ActionFactor Xa inhibitors
TargetsCoagulation factor X
Therapy Area/IndicationsThrombosisMyocardial Infarction
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryIsrael
CombinationsNo
Global Highest StatusDiscontinued (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesSavient Pharmaceuticals Inc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesSavient Pharmaceuticals Inc
Active IndicationsN/A
Inactive IndicationsThrombosisMyocardial Infarction

Other Information

ATC CodeN/A
Related LinksN/A